Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393
- 1 August 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 185 (2-3) , 209-215
- https://doi.org/10.1016/0014-2999(90)90642-j
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effect of D1 receptor stimulation in normal and MPTP monkeysNeuroscience Letters, 1989
- Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeysEuropean Journal of Pharmacology, 1988
- Dopaminergic mechanisms in hemiparkinsonian monkeysNeurology, 1987
- Selective D-1 dopamine receptor agonist treatment of parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Regional effect of estradiol on rat caudate-putamen dopamine receptors: lateral-medial differencesNeuroscience Letters, 1987
- Chronic treatment withl-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone bindingBrain Research, 1986
- Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeysBrain Research, 1986
- Failure of SKF 38393‐A to relieve parkinsonian symptoms induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the marmosetBritish Journal of Pharmacology, 1985
- Decreased tuberoinfundibular and pituitary dopamine and dihydroxyphenylacetic acid concentrations in rats with estrogen-induced pituitary tumorsNeuroscience Letters, 1985
- Bromocriptine in ParkinsonismBMJ, 1974